About us

Our Mission

Olaregen Therapeutix, Inc. is a regenerative medicine company focused on the development, manufacturing and commercialization of products that fill unmet needs in current wound healing market. The company aims to provide advanced healing solutions that substantially improve medical outcomes while lowering the overall cost of care. Olaregen’s first product introduction, Excellagen® (3-dimensional wound conforming matrix) is a topically applied product for dermal wounds and other medical conditions.

 

Olaregen Culture

Our culture is to understand each other, our wound care community, our employees and our patients.

We always put people first, anticipate their needs and deliver the highest levels of innovation and service.

We strive to have the best understanding of the patients whom we ultimately serve, and we develop our products with patients in mind.

Our passion for what we do drives us to continuously improve and expand the positive impact that we have on people and the world.

Excellagen_Box0.5-1

Mission Statement

  • Develop and manufacture state-of-the-art, high quality medical devices
  • Provide superior customer-centric services
  • Expand our market opportunities with Generex end-to-end solutions model, both domestic and international
  • Grow and generate new opportunities for the company, the patients, the customers and our employees
  • Generex Biotechnology is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies.

    Generex is building a new kind of healthcare company that extends beyond traditional models providing support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care.

    In addition to advancing a legacy portfolio of immune-oncology assets, medical devices, and diagnostics, the Company is focused on an acquisition strategy of strategic businesses that complement existing assets and provide immediate sources of revenue and working capital. Recent acquisitions include a management services organization, a network of pharmacies, clinical laboratory, and medical device companies with new and approved products. 

    Our newly formed, wholly-owned subsidiary, NuGenerex Distribution Solutions (NDS), integrates our MSO network with a pharmacy network, clinical diagnostic lab, durable medical equipment company (DME-IQ) and dedicated call center.

See what people are saying!

  • “We’ve loved every minute of our journey. When people need state of the art wound care regenerative medicine options, our expertise & experience will help patients navigate the PATH to healing”.

    Scott Emmens, Sr. VP of Sales and Business Development

1001 6th Ave, 2nd Fl, New York, NY 10018
info@olaregen.com
1-844 -WOUNDS4

1001 6th Ave, 2nd Fl, New York, NY 10018
info@olaregen.com
1-844 -WOUNDS4